References in Nitrosamines Exchange

[Yosukemino]

Thank you for your kind message, @Naiffer_Host. I hope everyone enjoys this fantastic journey in this community.

Risk assessment: root causes;

1. Avoiding N-nitrosodimethylamine formation in metformin pharmaceuticals by limiting dimethylamine and nitrite May 2022

2. Potential for the Formation of N -Nitrosamines during the Manufacture of Active Pharmaceutical Ingredients: An Assessment of the Risk Posed by Trace Nitrite in Water August 2020

3. Inhibition of N -Nitrosamine Formation in Drug Products: A Model Study December 2021

4. Pathways for N -Nitroso Compound Formation: Secondary Amines and Beyond July 2020

5. Nitrocellulose blister material as a source of N -nitrosamine contamination of pharmaceutical drug products April 2022

6. Evaluating Nitrosamines from Elastomers in Pharmaceutical Primary Packaging July 2021

7. Reaction of Irbesartan with Nitrous Acid Produces Irbesartan Oxime Derivatives, rather than N -Nitrosoirbesartan March 2022

8. Ranitidine—Investigations into the Root Cause for the Presence of N -Nitroso- N , N -dimethylamine in Ranitidine Hydrochloride Drug Substances and Associated Drug Products December 2020

9. Investigating the root cause of N-nitrosodimethylamine formation in metformin pharmaceutical products Apr 2021